WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000028990) PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE INSULIN SENSITISER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/028990    International Application No.:    PCT/EP1999/009031
Publication Date: 25.05.2000 International Filing Date: 12.11.1999
Chapter 2 Demand Filed:    05.06.2000    
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01), A61K 9/50 (2006.01), A61K 31/353 (2006.01), A61K 31/4439 (2006.01)
Applicants: SMITHKLINE BEECHAM P.L.C. [GB/GB]; New Horizons Court, Brentford, Middlesex TW8 9EP (GB) (For All Designated States Except US).
SMITHKLINE BEECHAM CORPORATION [US/US]; One Franklin Plaza, Philadelphia, PA 19103 (US) (For All Designated States Except US).
GLINECKE, Robert [US/US]; (US) (For US Only).
MILOSOVICH, Susan, Marie [US/US]; (US) (For US Only).
MULDOON, William [US/US]; (US) (For US Only).
RE, Vincenzo [GB/GB]; (GB) (For US Only).
SAUER, Joseph [US/US]; (US) (For US Only).
SKINNER, Janet, Louise [GB/GB]; (GB) (For US Only)
Inventors: GLINECKE, Robert; (US).
MILOSOVICH, Susan, Marie; (US).
MULDOON, William; (US).
RE, Vincenzo; (GB).
SAUER, Joseph; (US).
SKINNER, Janet, Louise; (GB)
Agent: RUTTER, Keith; SmithKline Beecham Corporate Intellectual Property, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB).
GIDDINGS , Peter, John; SmithKline Beecham, Corporate Intellectual Property, Two New Horizons Court, Brentford, Middlesex TW8 9EP (GB)
Priority Data:
9824870.1 12.11.1998 GB
9912189.9 25.05.1999 GB
Title (EN) PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE INSULIN SENSITISER
(FR) COMPOSITION PHARMACEUTIQUE DE SENSIBILISATEUR MODIFIANT LA LIBERATION D'INSULINE
Abstract: front page image
(EN)A pharmaceutical composition which composition comprises an insulin sensitiser and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of the insulin sensitiser and the use of such composition in medicine.
(FR)L'invention porte sur une composition pharmaceutique comportant un sensibilisateur d'insuline et un excipient pharmacocompatible, ladite composition étant conçue pour assurer une libération modifiée de l'insuline, et sur ses utilisations en médecine.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)